Ebola
Ebola, also known as Ebola virus disease (EVD) and Ebola hemorrhagic fever (EHF), is a zoonotic viral hemorrhagic fever in humans and other primates, caused by four of the six known ebolaviruses. Symptoms typically start anywhere between two days and three weeks after infection. The first symptoms are usually fever, sore throat, muscle pain, and headaches. These are usually followed by vomiting, diarrhoea, rash, hepatic and renal dysfunction, at which point some people begin to bleed both internally and externally. Outbreaks of the disease have had a mortality rate of between 25 and 90%, averaging out at approximately 50%. The viral species involved and timing of treatment play a critical role in its prognosis. Death is often due to shock from fluid loss, and typically occurs between 6 and 16 days after the first symptoms appear.
Beyond's analysis on Ebola
- — The escalating Ebola outbreak in the DRC threatens to disrupt global health supply chains and increase costs for insurers and pharma firms
- — Record‑speed Ebola treatment trial launches in DRC, testing two experimental drugs to curb mortality in the latest outbreak
- — The infection of a US aid worker with Ebola in the DRC raises safety concerns for international health missions and could boost demand for containment and risk‑mitigation services
- — French doctor’s Ebola recovery signals treatment advances, boosting confidence in biotech and health‑care investments
- — The escalating Ebola outbreak in the Democratic Republic of Congo threatens regional stability and could disrupt trade, healthcare spending, and insurance markets
- — France's first Ebola case since the current outbreak highlights biosecurity risks for European health and travel sectors
- — Kenya's intensifying alignment with the Trump administration fuels public protests over perceived sell‑out of national interests
Recent news mentioning Ebola
- — WHO Grants Emergency Use Listing for Cepheid's Xpert® Hemorrhagic Fever Panel Test to Support Ebola Outbreak Response in the DRC
- — Ebola im Kongo: Zahl der Ebola-Toten im Kongo auf über 3.000 gestiegen
- — Could AT&T (T)’s 5G Expansion Give it the Edge Over Telefonaktiebolaget LM Ericsson (publ) (ERIC)?
- — African Bundibugyo ebolavirus vaccine candidate to be advanced to clinical trials
- — Ebola day 100: why this outbreak could become the deadliest in history – video explainer
- — Ebola im Kongo: Trauer, Trauma, Stigma - Ebola-Waisen im Kongo
- — Ebola im Kongo: Ebola-Ausbruch nach 100 Tagen weiter nicht unter Kontrolle
- — Ebola outbreak: five big questions
- — Ebola im Kongo: Ebola-Ausbruch noch lange nicht unter Kontrolle
- — Ebola im Kongo: Bereits mehr als 5.000 bestätigte Ebola Fälle im Kongo
- — Ebola-Ausbruch: Deutschland stockt Ebola-Hilfe für Kongo auf
- — What is Ebola and why is the outbreak in DRC causing so much concern?